Вопросы вирусологии. 2019; 64: 262-267
Обзор актуальных вопросов диагностики и профилактики гемоконтактных нозокомиальных вирусных инфекций
https://doi.org/10.36233/0507-4088-2019-64-6-262-267Аннотация
В обзорной статье на основании данных зарубежной научной литературы показана необходимость внедрения дополнительных лабораторных тестов на возбудители актуальных гемоконтактных вирусных инфекций, связанных с оказанием медицинской помощи, с использованием риск-ориентированного подхода: на конкретных территориях и в группах высокого риска. Представлена методология определения количественного показателя остаточного риска трансфузионного инфицирования для оценки эффективности обеспечения вирусологической безопасности в Службе крови.
Список литературы
1. Moustafa A., Xie C., Kirkness E., Biggs W., Wong E., Turpaz Y., et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 2017; 13(3): e1006292. Doi: https://doi.org/10.1371/journal.ppat.1006292
2. Smith D.B., Becher P., Bukh J., Gould E.A., Meyers G., Monath T., et al. Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family. J. Gen. Virol. 2016; 97(11): 2894-907. Doi: https://doi.org/10.1099/jgv.0.000612
3. Stapleton J.T., Foung S., Muerhoff A.S., Bukh J., Simmonds P. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J. Gen. Virol. 2011; 92 (Pt. 2): 233-46. Doi: https://doi.org/10.1099/vir.0.027490-0
4. Genus: Pegivirus – Flaviviridae – Positive sense RNA viruses. International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_online_report/positivesense-rna-viruses/w/flaviviridae/363/genus-pegivirus/
5. Berg M.G., Lee D., Coller K., Frankel M., Aronsohn A., Cheng K., et al. Discovery of a novel human Pegivirus in blood associated with Hepatitis C virus co-Infection. PLoS Pathog. 2015; 11(12): e1005325. Doi: https://doi.org/10.1371/journal.ppat.1005325
6. Pisani G., Cristiano K., Pupella S., Liumbruno G.M. West Nile virus in Europe and safety of blood transfusion. Transfus. Med. Hemother. 2016; 43(3): 158-67. Doi: https://doi.org/10.1159/000446219
7. Goodnough L.T., Marques M.B. Zika virus and patient blood management. Anesth. Analg. 2017; 124(1): 282-9. Doi: https://doi.org/10.1213/ANE.0000000000001770
8. Marano G., Pupella S., Vaglio S., Liumbruno G.M., Grazzini G. Zika virus and the never-ending story of emerging pathogens and transfusion medicine. Blood Transfus. 2016; 14(2): 95-100. Doi: https://doi.org/10.2450/2015.0066-15
9. Pozzetto B., Memmi M., Garraud O. Is transfusion-transmitted dengue fever a potential public health threat? World J. Virol. 2015; 4(2): 113-23. Doi: https://doi.org/10.5501/wjv.v4.i2.113
10. Domanovic D., Tedder R., Blümel J., Zaaijer H., Gallian P., Niederhauser C., et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017; 22(16): pii: 30514. Doi: https://doi.org/10.2807/1560-7917.ES.2017.22.16.30514
11. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 1997; 241(1): 92-7. Doi: https://doi.org/10.1006/bbrc.1997.7765
12. Poovorawan Y., Tangkijvanich P., Theamboonlers A., Hirsch P. Transfusion transmissible virus TTV and its putative role in the etiology of liver disease. Hepatogastroenterology. 2001; 48(37): 256-60.
13. Ali S., Fevery J., Peerlinck K., Verslype C., Schelstraete R., Gyselinck F., et al. TTV infection and its relation to serum transaminases in apparently healthy blood donors and in patients with clotting disorders who have been investigated previously for hepatitis C virus and GBV-C/HGV infection in Belgium. J. Med. Virol. 2002; 66(4): 561-6.
14. Parvoviridae – ssDNA viruses (2011) – ssDNA viruses (2011). International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_9th_report/ssdna-viruses-2011/w/ssdna_viruses/151/parvoviridae/
15. Nagaharu K., Sugimoto Y., Hoshi Y., Yamaguchi T., Ito R., Matsubayashi K., et al. Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels. Transfusion. 2017; 57(6): 1414-8. Doi: https://doi.org/10.1111/trf.14088
16. Jones M.S., Kapoor A., Lukashov V.V., Simmonds P., Hecht F., Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J. Virol. 2005; 79(13): 8230-6. Doi: https://doi.org/10.1128/JVI.79.13.8230-8236.2005
17. Sharp C.P., Lail A., Donfield S., Gomperts E.D., Simmonds P. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion. 2012; 52(7): 1482-9. Doi: https://doi.org/10.1111 / j.1537-2995.2011.03420.x
18. Anelloviridae – ssDNA viruses (2011) – ssDNA viruses (2011). International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_9th_report/ssdna-viruses-2011/w/ssdna_viruses/139/anelloviridae/
19. Soldan K., Davison K. How to assess risk: prospective studies and calculations. In: Barbara J.A.J., Regan F.A.M., Contreras M.C., eds. Transfusion Microbiology. Cambridge: Cambridge University Press; 2008: 330-40.
Problems of Virology. 2019; 64: 262-267
Review of current issues of diagnosis and prevention of blood-borne nosocomial viral infections
https://doi.org/10.36233/0507-4088-2019-64-6-262-267Abstract
The review article demonstrates the need for implementation of additional laboratory tests for the agents of the priority healthcare-associated blood-borne infections (HAI) using a risk-based approach, i.e., on specified sites and in high risk groups. It presents a methodology for determination of a quantitative blood-induced infection residual risk (BIRR) index to be used while evaluating the efficiency of viral security provision in the blood service.
References
1. Moustafa A., Xie C., Kirkness E., Biggs W., Wong E., Turpaz Y., et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 2017; 13(3): e1006292. Doi: https://doi.org/10.1371/journal.ppat.1006292
2. Smith D.B., Becher P., Bukh J., Gould E.A., Meyers G., Monath T., et al. Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family. J. Gen. Virol. 2016; 97(11): 2894-907. Doi: https://doi.org/10.1099/jgv.0.000612
3. Stapleton J.T., Foung S., Muerhoff A.S., Bukh J., Simmonds P. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J. Gen. Virol. 2011; 92 (Pt. 2): 233-46. Doi: https://doi.org/10.1099/vir.0.027490-0
4. Genus: Pegivirus – Flaviviridae – Positive sense RNA viruses. International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_online_report/positivesense-rna-viruses/w/flaviviridae/363/genus-pegivirus/
5. Berg M.G., Lee D., Coller K., Frankel M., Aronsohn A., Cheng K., et al. Discovery of a novel human Pegivirus in blood associated with Hepatitis C virus co-Infection. PLoS Pathog. 2015; 11(12): e1005325. Doi: https://doi.org/10.1371/journal.ppat.1005325
6. Pisani G., Cristiano K., Pupella S., Liumbruno G.M. West Nile virus in Europe and safety of blood transfusion. Transfus. Med. Hemother. 2016; 43(3): 158-67. Doi: https://doi.org/10.1159/000446219
7. Goodnough L.T., Marques M.B. Zika virus and patient blood management. Anesth. Analg. 2017; 124(1): 282-9. Doi: https://doi.org/10.1213/ANE.0000000000001770
8. Marano G., Pupella S., Vaglio S., Liumbruno G.M., Grazzini G. Zika virus and the never-ending story of emerging pathogens and transfusion medicine. Blood Transfus. 2016; 14(2): 95-100. Doi: https://doi.org/10.2450/2015.0066-15
9. Pozzetto B., Memmi M., Garraud O. Is transfusion-transmitted dengue fever a potential public health threat? World J. Virol. 2015; 4(2): 113-23. Doi: https://doi.org/10.5501/wjv.v4.i2.113
10. Domanovic D., Tedder R., Blümel J., Zaaijer H., Gallian P., Niederhauser C., et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017; 22(16): pii: 30514. Doi: https://doi.org/10.2807/1560-7917.ES.2017.22.16.30514
11. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 1997; 241(1): 92-7. Doi: https://doi.org/10.1006/bbrc.1997.7765
12. Poovorawan Y., Tangkijvanich P., Theamboonlers A., Hirsch P. Transfusion transmissible virus TTV and its putative role in the etiology of liver disease. Hepatogastroenterology. 2001; 48(37): 256-60.
13. Ali S., Fevery J., Peerlinck K., Verslype C., Schelstraete R., Gyselinck F., et al. TTV infection and its relation to serum transaminases in apparently healthy blood donors and in patients with clotting disorders who have been investigated previously for hepatitis C virus and GBV-C/HGV infection in Belgium. J. Med. Virol. 2002; 66(4): 561-6.
14. Parvoviridae – ssDNA viruses (2011) – ssDNA viruses (2011). International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_9th_report/ssdna-viruses-2011/w/ssdna_viruses/151/parvoviridae/
15. Nagaharu K., Sugimoto Y., Hoshi Y., Yamaguchi T., Ito R., Matsubayashi K., et al. Persistent symptomatic parvovirus B19 infection with severe thrombocytopenia transmitted by red blood cell transfusion containing low parvovirus B19 DNA levels. Transfusion. 2017; 57(6): 1414-8. Doi: https://doi.org/10.1111/trf.14088
16. Jones M.S., Kapoor A., Lukashov V.V., Simmonds P., Hecht F., Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J. Virol. 2005; 79(13): 8230-6. Doi: https://doi.org/10.1128/JVI.79.13.8230-8236.2005
17. Sharp C.P., Lail A., Donfield S., Gomperts E.D., Simmonds P. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion. 2012; 52(7): 1482-9. Doi: https://doi.org/10.1111 / j.1537-2995.2011.03420.x
18. Anelloviridae – ssDNA viruses (2011) – ssDNA viruses (2011). International Committee on Taxonomy of Viruses. Available at: http://talk.ictvonline.org/ictv-reports/ictv_9th_report/ssdna-viruses-2011/w/ssdna_viruses/139/anelloviridae/
19. Soldan K., Davison K. How to assess risk: prospective studies and calculations. In: Barbara J.A.J., Regan F.A.M., Contreras M.C., eds. Transfusion Microbiology. Cambridge: Cambridge University Press; 2008: 330-40.
